Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates

Group 1 - Penumbra reported quarterly earnings of $0.97 per share, exceeding the Zacks Consensus Estimate of $0.91 per share, and up from $0.76 per share a year ago, representing an earnings surprise of 6.59% [1] - The company achieved revenues of $315.52 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.07%, and an increase from $284.68 million year-over-year [2] - Over the last four quarters, Penumbra has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Group 2 - Penumbra shares have increased approximately 13.1% since the beginning of the year, outperforming the S&P 500's gain of 4% [3] - The current consensus EPS estimate for the upcoming quarter is $0.82 on revenues of $318.45 million, and for the current fiscal year, it is $3.86 on revenues of $1.37 billion [7] - The Medical - Instruments industry, to which Penumbra belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook [8]